{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:33:09Z","timestamp":1759624389654,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":5425,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.exphem.2007.04.012","type":"journal-article","created":{"date-parts":[[2007,6,8]],"date-time":"2007-06-08T12:54:36Z","timestamp":1181307276000},"page":"1231-1239","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells"],"prefix":"10.1016","volume":"35","author":[{"given":"Won-Il","family":"Kim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Wiesner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A.","family":"Largaespada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2007.04.012_bib1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1182\/blood.V91.2.419","article-title":"Transcriptional regulation of vav, a gene expressed throughout the hematopoietic compartment","volume":"91","author":"Ogilvy","year":"1998","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.04.012_bib2","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1182\/blood.V94.6.1855","article-title":"Promoter elements of vav drive transgene expression in vivo throughout the hematopoietic compartment","volume":"94","author":"Ogilvy","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.04.012_bib3","doi-asserted-by":"crossref","first-page":"14943","DOI":"10.1073\/pnas.96.26.14943","article-title":"Constitutive Bcl-2 expression throughout the hematopoietic compartment affects multiple lineages and enhances progenitor cell survival","volume":"96","author":"Ogilvy","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2007.04.012_bib4","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1002\/j.1460-2075.1989.tb08354.x","article-title":"vav, a novel human oncogene derived from a locus ubiquitously expressed in hematopoietic cells","volume":"8","author":"Katzav","year":"1989","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2007.04.012_bib5","first-page":"473","article-title":"Hematopoietic commitment during embryonic stem cell differentiation in culture","volume":"13","author":"Keller","year":"1993","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2007.04.012_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/j.1460-2075.1995.tb06969.x","article-title":"The vav proto-oncogene is required early in embryogenesis but not for hematopoietic development in vitro","volume":"14","author":"Zmuidzinas","year":"1995","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2007.04.012_bib7","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1084\/jem.20011701","article-title":"Vav1 is a component of transcriptionally active complexes","volume":"195","author":"Houlard","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.exphem.2007.04.012_bib8","first-page":"297","article-title":"Developmental expression of the vav protooncogene","volume":"4","author":"Bustelo","year":"1993","journal-title":"Cell Growth Differ"},{"key":"10.1016\/j.exphem.2007.04.012_bib9","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/385169a0","article-title":"Phosphotyrosine-dependent activation of Rac-1 GDP\/GTP exchange by the vav proto-oncogene product","volume":"385","author":"Crespo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.exphem.2007.04.012_bib10","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S1074-7613(00)80367-2","article-title":"A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes","volume":"7","author":"Turner","year":"1997","journal-title":"Immunity"},{"key":"10.1016\/j.exphem.2007.04.012_bib11","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1073\/pnas.96.6.3035","article-title":"The Rho-family GTP exchange factor Vav is a critical transducer of T cell receptor signals to the calcium, ERK, and NF-kappaB pathways","volume":"96","author":"Costello","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2007.04.012_bib12","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1093\/emboj\/cdg316","article-title":"Vav mediates Ras stimulation by direct activation of the GDP\/GTP exchange factor Ras GRP1","volume":"22","author":"Caloca","year":"2003","journal-title":"EMBO J"},{"key":"10.1016\/j.exphem.2007.04.012_bib13","doi-asserted-by":"crossref","first-page":"5268","DOI":"10.1038\/sj.onc.1202997","article-title":"Transgenic models of lymphoid neoplasia and development of a pan-hematopoietic vector","volume":"18","author":"Adams","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2007.04.012_bib14","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1038\/sj.onc.1207048","article-title":"Vav-promoter regulated oncogenic fusion protein NPM-ALK in transgenic mice causes B-cell lymphomas with hyperactive Jun kinase","volume":"22","author":"Turner","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2007.04.012_bib15","doi-asserted-by":"crossref","first-page":"7882","DOI":"10.1038\/sj.onc.1208933","article-title":"FLT3 internal tandem duplication mutations induce myeloproliferative or lymphoid disease in a transgenic mouse model","volume":"24","author":"Lee","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2007.04.012_bib16","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1182\/blood-2004-08-3306","article-title":"Repressible transgenic model of NRAS oncogene-driven mast cell disease in the mouse","volume":"106","author":"Wiesner","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.04.012_bib17","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.exphem.2004.01.005","article-title":"Regulatory elements of the vav gene drive transgene expression in hematopoietic stem cells from adult mice","volume":"32","author":"Almarza","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2007.04.012_bib18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/gene.10161","article-title":"VavCre transgenic mice: a tool for mutagenesis in hematopoietic and endothelial lineages","volume":"34","author":"Georgiades","year":"2002","journal-title":"Genesis"},{"key":"10.1016\/j.exphem.2007.04.012_bib19","doi-asserted-by":"crossref","first-page":"5547","DOI":"10.1073\/pnas.89.12.5547","article-title":"Tight control of gene expression in mammalian cells by tetracycline-responsive promoters","volume":"89","author":"Gossen","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2007.04.012_bib20","doi-asserted-by":"crossref","first-page":"10933","DOI":"10.1073\/pnas.93.20.10933","article-title":"Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice","volume":"93","author":"Kistner","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2007.04.012_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1472-6750-6-30","article-title":"Conditional gene expression in the mouse using a Sleeping Beauty gene-trap transposon","volume":"6","author":"Geurts","year":"2006","journal-title":"BMC Biotechnol"},{"key":"10.1016\/j.exphem.2007.04.012_bib22","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1182\/blood-2005-08-3522","article-title":"Implications of NRAS mutations in AML: a study of 2502 patients","volume":"107","author":"Bacher","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.04.012_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3109\/00313029309068903","article-title":"N-ras mutation in acute myeloid leukemia: incidence, prognostic significance and value as a marker of minimal residual disease","volume":"25","author":"Casey","year":"1993","journal-title":"Pathology"},{"key":"10.1016\/j.exphem.2007.04.012_bib24","doi-asserted-by":"crossref","first-page":"4579","DOI":"10.1182\/blood.V86.12.4579.bloodjournal86124579","article-title":"Monosomy 7 and activating RAS mutations accompany malignant transformation in patients with congenital neutropenia","volume":"86","author":"Kalra","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.04.012_bib25","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/stem.5530130514","article-title":"Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia","volume":"13","author":"Lee","year":"1995","journal-title":"Stem Cells"},{"key":"10.1016\/j.exphem.2007.04.012_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/gcc.2870020212","article-title":"RAS gene mutations in childhood acute myeloid leukemia: a Pediatric Oncology Group study","volume":"2","author":"Vogelstein","year":"1990","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.exphem.2007.04.012_bib27","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.1016\/S0006-3495(01)75979-6","article-title":"Molecular dynamics simulations of Gly-12\u2192Val mutant of p21(ras): dynamic inhibition mechanism","volume":"81","author":"Futatsugi","year":"2001","journal-title":"Biophys J"},{"key":"10.1016\/j.exphem.2007.04.012_bib28","doi-asserted-by":"crossref","first-page":"11076","DOI":"10.1074\/jbc.271.19.11076","article-title":"Involvement of the switch 2 domain of Ras in its interaction with guanine nucleotide exchange factors","volume":"271","author":"Quilliam","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2007.04.012_bib29","first-page":"2583","article-title":"Identification of amino acids in p21ras involved in exchange factor interaction","volume":"8","author":"Howe","year":"1993","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2007.04.012_bib30","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ng0296-137","article-title":"Nf1 deficiency causes Ras-mediated granulocyte\/macrophage colony stimulating factor hypersensitivity and chronic myeloid leukaemia","volume":"12","author":"Largaespada","year":"1996","journal-title":"Nat Genet"},{"key":"10.1016\/j.exphem.2007.04.012_bib31","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1038\/sj.gt.3301835","article-title":"Hypothalamic delivery of doxycycline-inducible leptin gene allows for reversible transgene expression and physiological responses","volume":"9","author":"Wilsey","year":"2002","journal-title":"Gene Ther"},{"key":"10.1016\/j.exphem.2007.04.012_bib32","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.neulet.2004.08.008","article-title":"Bone marrow-derived mast cells in mice respond in co-culture to scorpion venom activation of superior cervical ganglion neurites according to level of expression of NK-1 receptors","volume":"372","author":"Furuno","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.exphem.2007.04.012_bib33","doi-asserted-by":"crossref","first-page":"12580","DOI":"10.1073\/pnas.95.21.12580","article-title":"Doxycycline control of prion protein transgene expression modulates prion disease in mice","volume":"95","author":"Tremblay","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2007.04.012_bib34","doi-asserted-by":"crossref","first-page":"12236","DOI":"10.1073\/pnas.192255099","article-title":"Experimental control of pancreatic development and maintenance","volume":"99","author":"Holland","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2007.04.012_bib35","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.exphem.2005.11.015","article-title":"Establishment of a murine model of aggressive systemic mastocytosis\/mast cell leukemia","volume":"34","author":"Demehri","year":"2006","journal-title":"Exp Hematol"},{"key":"10.1016\/j.exphem.2007.04.012_bib36","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/immu.200310005","article-title":"Transgenic mice with hematopoietic and lymphoid specific expression of Cre","volume":"33","author":"de Boer","year":"2003","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.exphem.2007.04.012_bib37","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ijc.2910530628","article-title":"Conditional expression and oncogenicity of c-myc linked to a CD2 gene dominant control region","volume":"53","author":"Stewart","year":"1993","journal-title":"Int J Cancer"},{"key":"10.1016\/j.exphem.2007.04.012_bib38","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.4049\/jimmunol.155.3.1286","article-title":"Functional dissection of the murine lck distal promoter","volume":"155","author":"Wildin","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2007.04.012_bib39","doi-asserted-by":"crossref","first-page":"6725","DOI":"10.4049\/jimmunol.174.11.6725","article-title":"Selective expression of the Cre recombinase in late-stage thymocytes using the distal promoter of the Lck gene","volume":"174","author":"Zhang","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.exphem.2007.04.012_bib40","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.0019-2805.2002.01376.x","article-title":"Conditional ablation of T-cell development by a novel viral ion channel transgene","volume":"105","author":"Smith","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.exphem.2007.04.012_bib41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1093\/intimm\/7.1.89","article-title":"Regulated activity of the IgH intron enhancer (E mu) in the T lymphocyte lineage","volume":"7","author":"Cook","year":"1995","journal-title":"Int Immunol"},{"key":"10.1016\/j.exphem.2007.04.012_bib42","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1182\/blood-2003-06-2116","article-title":"E mu-BRD2 transgenic mice develop B-cell lymphoma and leukemia","volume":"103","author":"Greenwald","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.04.012_bib43","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1128\/MCB.21.5.1531-1539.2001","article-title":"The B lymphocyte-specific coactivator BOB.1\/OBF.1 is required at multiple stages of B-cell development","volume":"21","author":"Hess","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.exphem.2007.04.012_bib44","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1182\/blood-2005-12-012104","article-title":"Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-kit-expressing lineage-negative hematopoietic cells","volume":"108","author":"Bockamp","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.04.012_bib45","doi-asserted-by":"crossref","first-page":"4410","DOI":"10.1182\/blood-2002-02-0355","article-title":"Transgenic targeting with regulatory elements of the human CD34 gene","volume":"100","author":"Radomska","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2007.04.012_bib46","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1182\/blood-2004-08-009498","article-title":"Oncogenic NRAS rapidly and efficiently induces CMML- and AML-like diseases in mice","volume":"108","author":"Parikh","year":"2006","journal-title":"Blood"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X07002615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X07002615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:23:38Z","timestamp":1759566218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X07002615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0301472X07002615"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2007.04.012","relation":{},"ISSN":["0301-472X"],"issn-type":[{"type":"print","value":"0301-472X"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vav promoter-tTA conditional transgene expression system for hematopoietic cells drives high level expression in developing B and T cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2007.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 ISEH - Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}